Trials / Completed
CompletedNCT05278260
Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients
Hydrogen Rich Water to Mitigate Acute Mucositis During Radiation Therapy
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Stony Brook University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study explores the effects of hydrogen-rich water on alleviating the radiation-induced acute mucositis in head and neck cancer patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Hydrogen tablets | Participants will drink up to 1000 ml (34 fl. oz.) of water daily supplemented with a tablet that releases molecular hydrogen, for the duration of the radiation therapy |
| DIETARY_SUPPLEMENT | Control | Participants will drink up to 1000 ml (34 fl. oz.) of water daily supplemented with a tablet that does not release any molecular hydrogen, for the duration of the radiation therapy |
Timeline
- Start date
- 2022-05-25
- Primary completion
- 2024-11-13
- Completion
- 2024-11-13
- First posted
- 2022-03-14
- Last updated
- 2025-05-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05278260. Inclusion in this directory is not an endorsement.